These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16378590)

  • 21. Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients.
    Gidaro T; Negroni E; Perié S; Mirabella M; Lainé J; Lacau St Guily J; Butler-Browne G; Mouly V; Trollet C
    J Neuropathol Exp Neurol; 2013 Mar; 72(3):234-43. PubMed ID: 23399899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging.
    Anvar SY; Raz Y; Verway N; van der Sluijs B; Venema A; Goeman JJ; Vissing J; van der Maarel SM; 't Hoen PA; van Engelen BG; Raz V
    Aging (Albany NY); 2013 Jun; 5(6):412-26. PubMed ID: 23793615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing.
    Klein P; Oloko M; Roth F; Montel V; Malerba A; Jarmin S; Gidaro T; Popplewell L; Perie S; Lacau St Guily J; de la Grange P; Antoniou MN; Dickson G; Butler-Browne G; Bastide B; Mouly V; Trollet C
    Nucleic Acids Res; 2016 Dec; 44(22):10929-10945. PubMed ID: 27507886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1.
    Tavanez JP; Calado P; Braga J; Lafarga M; Carmo-Fonseca M
    RNA; 2005 May; 11(5):752-62. PubMed ID: 15811916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1.
    Chartier A; Benoit B; Simonelig M
    EMBO J; 2006 May; 25(10):2253-62. PubMed ID: 16642034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial localization of PABPN1 in oculopharyngeal muscular dystrophy.
    Doki T; Yamashita S; Wei FY; Hara K; Yamamoto T; Zhang Z; Zhang X; Tawara N; Hino H; Uyama E; Kurashige T; Maruyama H; Tomizawa K; Ando Y
    Lab Invest; 2019 Nov; 99(11):1728-1740. PubMed ID: 30894671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Established PABPN1 intranuclear inclusions in OPMD muscle can be efficiently reversed by AAV-mediated knockdown and replacement of mutant expanded PABPN1.
    Malerba A; Klein P; Lu-Nguyen N; Cappellari O; Strings-Ufombah V; Harbaran S; Roelvink P; Suhy D; Trollet C; Dickson G
    Hum Mol Genet; 2019 Oct; 28(19):3301-3308. PubMed ID: 31294444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myogenic progenitor cells in the mouse embryo are marked by the expression of Pax3/7 genes that regulate their survival and myogenic potential.
    Buckingham M; Bajard L; Daubas P; Esner M; Lagha M; Relaix F; Rocancourt D
    Anat Embryol (Berl); 2006 Dec; 211 Suppl 1():51-6. PubMed ID: 17039375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology.
    Vest KE; Phillips BL; Banerjee A; Apponi LH; Dammer EB; Xu W; Zheng D; Yu J; Tian B; Pavlath GK; Corbett AH
    Hum Mol Genet; 2017 Sep; 26(17):3235-3252. PubMed ID: 28575395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease.
    Brais B
    Cytogenet Genome Res; 2003; 100(1-4):252-60. PubMed ID: 14526187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of expression and co-localization of heat shock polypeptides with the polyalanine expansion mutant of poly(A)-binding protein N1 after chemical stress.
    Wang Q; Bag J
    Biochem Biophys Res Commun; 2008 May; 370(1):11-5. PubMed ID: 18343218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy.
    Mankodi A; Wheeler TM; Shetty R; Salceies KM; Becher MW; Thornton CA
    Neurobiol Dis; 2012 Jan; 45(1):539-46. PubMed ID: 21964252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy.
    Davies JE; Rose C; Sarkar S; Rubinsztein DC
    Sci Transl Med; 2010 Jun; 2(34):34ra40. PubMed ID: 20519718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hsp70 chaperones and type I PRMTs are sequestered at intranuclear inclusions caused by polyalanine expansions in PABPN1.
    Tavanez JP; Bengoechea R; Berciano MT; Lafarga M; Carmo-Fonseca M; Enguita FJ
    PLoS One; 2009 Jul; 4(7):e6418. PubMed ID: 19641605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice.
    Davies JE; Wang L; Garcia-Oroz L; Cook LJ; Vacher C; O'Donovan DG; Rubinsztein DC
    Nat Med; 2005 Jun; 11(6):672-7. PubMed ID: 15864313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PABPN1 gene therapy for oculopharyngeal muscular dystrophy.
    Malerba A; Klein P; Bachtarzi H; Jarmin SA; Cordova G; Ferry A; Strings V; Espinoza MP; Mamchaoui K; Blumen SC; St Guily JL; Mouly V; Graham M; Butler-Browne G; Suhy DA; Trollet C; Dickson G
    Nat Commun; 2017 Mar; 8():14848. PubMed ID: 28361972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres.
    Trollet C; Anvar SY; Venema A; Hargreaves IP; Foster K; Vignaud A; Ferry A; Negroni E; Hourde C; Baraibar MA; 't Hoen PA; Davies JE; Rubinsztein DC; Heales SJ; Mouly V; van der Maarel SM; Butler-Browne G; Raz V; Dickson G
    Hum Mol Genet; 2010 Jun; 19(11):2191-207. PubMed ID: 20207626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing.
    Banerjee A; Vest KE; Pavlath GK; Corbett AH
    Nucleic Acids Res; 2017 Oct; 45(18):10706-10725. PubMed ID: 28977530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Inhibition of Heat Shock Protein 90 Facilitates the Degradation of Poly-Alanine Expanded Poly (A) Binding Protein Nuclear 1 via the Carboxyl Terminus of Heat Shock Protein 70-Interacting Protein.
    Shi C; Huang X; Zhang B; Zhu D; Luo H; Lu Q; Xiong WC; Mei L; Luo S
    PLoS One; 2015; 10(9):e0138936. PubMed ID: 26414348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody.
    Verheesen P; de Kluijver A; van Koningsbruggen S; de Brij M; de Haard HJ; van Ommen GJ; van der Maarel SM; Verrips CT
    Hum Mol Genet; 2006 Jan; 15(1):105-11. PubMed ID: 16319127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.